Dolan Christine's most recent trade in Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A was a trade of 28,934 Class A Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on Jan. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.69 per share. | 15 Jan 2026 | 28,934 | 448,973 | - | 3.7 | 106,766 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 1.79 per share. | 14 Nov 2025 | 4,300 | 477,907 | - | 1.8 | 7,697 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 1.67 per share. | 15 May 2025 | 2,381 | 473,607 | - | 1.7 | 3,976 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 246,549 | 471,226 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.64 per share. | 17 Mar 2025 | 5,336 | 224,677 | - | 2.6 | 14,087 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 18 Feb 2025 | 1,621 | 230,013 | - | 4.1 | 6,646 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 28,704 | 231,634 | - | 4.6 | 130,890 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 5.70 per share. | 31 Oct 2024 | 1,848 | 260,338 | - | 5.7 | 10,534 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 5.70 per share. | 30 Apr 2024 | 483 | 258,490 | - | 5.7 | 2,753 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. | 15 Mar 2024 | 5,383 | 258,007 | - | 7.7 | 41,449 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.48 per share. | 15 Feb 2024 | 1,941 | 263,390 | - | 5.5 | 10,637 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Dolan Christine | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 189,604 | 265,331 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 11.72 per share. | 28 Apr 2023 | 1,394 | 73,998 | - | 11.7 | 16,338 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 110,000 | 110,000 | - | - | Employee Stock Options (Right to Buy) | |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 55,775 | 72,604 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. | 15 Feb 2023 | 1,956 | 16,829 | - | 15.2 | 29,790 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 22.95 per share. | 29 Apr 2022 | 666 | 18,785 | - | 23.0 | 15,285 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 31,500 | 31,500 | - | - | Employee Stock Option (Right to Buy) | |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 17,000 | 18,119 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 22.95 per share. | 25 Jan 2022 | 916 | 916 | - | 22.9 | 21,022 | Class A Common Stock |
| Maravai LifeSciences Holdings Inc (Class A) | Christine Dolan | See Remarks | Grant, award, or other acquisition of securities at price $ 22.95 per share. | 25 Jan 2022 | 203 | 1,119 | - | 23.0 | 4,659 | Class A Common Stock |